About: non-alcoholic fatty liver

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: non-alcoholic fatty liver Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

nonalcoholic fatty liver disease that is characterized by the presence of at least 5% of hepatic steatosis with no evidence of hepatocellular injury in the form of hepatocyte ballooning

Attributes	Values
rdf:type	Item
description	nonalcoholic fatty liver disease that is characterized by the presence of at least 5% of hepatic steatosis with no evidence of hepatocellular injury in the form of hepatocyte ballooning (en)
exact match	wds:Q66299798-6761205A-FBCF-4E65-A8B2-6536776C5BC6 wds:Q66299798-FF3A2DE2-33FF-4B5E-A294-E2C69175AD50
exact match	http://identifiers.org/doid/DOID:0080546 http://purl.obolibrary.org/obo/DOID_0080546
Disease Ontology ID	wds:Q66299798-4F70198D-CC4A-44A8-9FF2-195498AF12A8
Disease Ontology ID	http://purl.obolibrary.org/obo/DOID_DOID:0080546
Disease Ontology ID	DOID:0080546
rdfs:label	nealkoholna zamaščenost jeter (sl) non-alcoholic fatty liver (en)
skos:prefLabel	nealkoholna zamaščenost jeter (sl) non-alcoholic fatty liver (en)
name	nealkoholna zamaščenost jeter (sl) non-alcoholic fatty liver (en)
instance of	wds:Q66299798-20DD2CE8-C675-4A21-97AA-32A0A685D20A
instance of	class of disease
subclass of	wds:Q66299798-371AB35F-BAAE-4C71-A654-9D8429FB8A15
subclass of	metabolic dysfunction–associated steatotic liver disease
skos:altLabel	NAFL (en)
on focus list of Wikimedia project	wds:Q66299798-03BE22C8-1004-4526-B9DD-E3D18357C0E3
ICD-11 (foundation)	wds:Q66299798-6f7d6e57-41c0-f694-0f19-871924b3b35e
on focus list of Wikimedia project	WikiProject Medicine
ICD-11 (foundation)	1331941447
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66299798
is main subject of	Obesity and non-alcoholic fatty liver disease in chronic hepatitis C. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice. Non-alcoholic fatty liver disease proteomics Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease Non-alcoholic fatty liver disease in older people. Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies Menopausal stages and non-alcoholic fatty liver disease in middle-aged women Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. Pathogenesis of non-alcoholic fatty liver disease. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Does fructose consumption contribute to non-alcoholic fatty liver disease? Serum chemerin and vaspin in non-alcoholic fatty liver disease Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD) Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. Letter: Is visceral adiposity index a predictor of liver histology in patients with non-alcoholic fatty liver disease? Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease Fructose consumption as a risk factor for non-alcoholic fatty liver disease Treatment of non-alcoholic fatty liver disease. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in rats Non-alcoholic fatty liver disease: current concepts and management strategies. Role of mitochondria in non-alcoholic fatty liver disease Hepatic lipid metabolism and non-alcoholic fatty liver disease. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. Non-alcoholic fatty liver disease Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease Nutrition and metabolism: non-alcoholic fatty liver disease - pathogenesis, cardiovascular risk and therapy Non-alcoholic fatty liver disease: when to intervene and with what Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease Genetic modifiers of non-alcoholic fatty liver disease progression Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease Associations between longer habitual day napping and non-alcoholic fatty liver disease in an elderly Chinese population Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population Systemic symptoms in non-alcoholic fatty liver disease Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. Non-alcoholic fatty liver disease: need for a balanced nutritional source Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background Clinical approaches to non-alcoholic fatty liver disease Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software